Introduction
Can the Progression of Coronary Sclerosis Be Influenced by Calcium Antagonists?
Calcium Antagonists in the Treatment of Essential Hypertension
Calcium Antagonists in the Treatment of Hypertension and Angina Pectoris in the Elderly
Verapamil Sustained-Release in Renal Parenchymal Hypertension
Antihypertensive, Anticalcinotic, and Antiarteriosclerotic Properties of Anipamil, a Long-Acting New Derivative of Verapamil
Treatment with Calcium Antagonists
Effects of Sustained-Release Verapamil on 24-Hour Ambulatory Blood Pressure and on Pressor Response to Isometric Exertion in Hypertensive Patients
The Efficacy and Duration of Action of Sustained-Release Verapamil in Essential Hypertension
Noninvasive Blood Pressure Monitoring Evaluation of Verapamil Slow-Release 240-mg Antihypertensive Effectiveness
The Effects of Slow-Release Verapamil on Blood Pressure and Cardiovascular System in Essential Hypertension
Treatment of Isolated Systolic Hypertension in the Elderly with Verapamil Slow-Release 240 mg
Efficacy and Safety of Verapamil SR 240 mg in Essential Hypertension
Treatment of Mild to Moderate Hypertension with Verapamil Slow-Release in Outpatients
Comparative Efficacy, Safety, and Kinetics of Immediate-and Slow-Release Verapamil in Hispanic Patients with Essential Hypertension
Sustained-Release Verapamil
The Effects of Age on the Pharmacodynamics and Pharmacokinetics of Two Formulations of Verapamil
Serum Gonadotropins in Postmenopausal Women After Long-Term Verapamil Treatment
Treatment of Resistant Hypertension
A Double-Blind, Randomized, Crossover Comparison of Equivalent (by Weight) Oral Doses of Verapamil and Diltiazem in Patients with Mild to Moderate Hypertension
Verapamil Versus Nicardipine in Rest and Exercise Hypertension
Effects of Anipamil on Electrocardiogram, Plasma Creatine Kinase, and Reperfusion Arrhythmias After Coronary Occlusion in Closed-Chest Rats
Antihypertensive Efficacy of Anipamil in Mild to Moderate Hypertension
Development of Hypertension and Life Span in Stroke-Prone Spontaneously Hypertensive Rats During Oral Long-Term Treatment with Various Antihypertensive Drugs